Neuraptive Therapeutics, Inc. — Form D
Neuraptive Therapeutics, Inc. of Louisville, CO, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-08. The offering totals $1.0M, of which $25K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-08
- Form: D
- Accession: 0001713836-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $25K
- Remaining: $975K
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2017-07-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-292379
Issuer
- Name: Neuraptive Therapeutics, Inc.
- CIK: 0001713836
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 168 CTC Blvd Suite 1930, Louisville, CO, 80027
- Phone: 303-736-9657
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| David Jackson | Director | Louisville, CO |
| David Jackson | Executive Officer | Louisville, CO |
| David Jackson | Related Person | Louisville, CO |
| Randy S Hubbell | Director | Philadelphia, PA |
| Robert S Radie | Director | Philadelphia, PA |
| Robert S Radie | Executive Officer | Philadelphia, PA |
| Greg S Parekh | Director | Philadelphia, PA |
| David S Pierce | Director | Philadelphia, PA |
| Ivan S Gergel | Director | Philadelphia, PA |
| David S Jackson | Director | Philadelphia, PA |
| Evan S Tzanis | Executive Officer | Philadelphia, PA |
| Gino DiSciullo | Director | Lafayette, CO |
| Gino DiSciullo | Related Person | Lafayette, CO |
| Greg Parekh | Director | Philadelphia, PA |
| Greg Parekh | Related Person | Philadelphia, PA |
| Ivan Gergel | Director | Philadelphia, PA |
| Ivan Gergel | Related Person | Philadelphia, PA |
| Randy Hubbell | Director | Pittsburgh, PA |
| Randy Hubbell | Related Person | Pittsburgh, PA |
| David M Jackson | Director | Winter Park, CO |
| David M Jackson | Executive Officer | Winter Park, CO |
Other filings by this issuer (3)
More